Related Experiment Video
Updated: Aug 26, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Expression and activation of the farnesoid X receptor in the vasculature
David Bishop-Bailey1, Desmond T Walsh, Timothy D Warner
1Cardiac, Vascular, and Inflammation Research, William Harvey Research Institute, Barts and the London, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom. d.bishop-bailey@qmul.ac.uk
Abstract:
The farnesoid X receptor/bile acid receptor (FXR) is a recently discovered member of the nuclear hormone superfamily. FXR ligands have been proposed as targets in cardiovascular disease, regulating cholesterol metabolism and bile acid transport and metabolism in the liver and gastrointestinal tract. When we used a human cardiovascular tissue array, we found that FXR is expressed in a variety of normal and pathological human tissue. Particularly high levels of FXR were found in the vasculature and in a number of different metastatic cancers, as well as the previously identified target tissues of the liver, small intestine, and kidney. In vitro, FXR is present in rat and human vascular smooth muscle cells. When treated with a range of FXR ligands, vascular smooth muscle cells undergo apoptosis in a manner that correlates with the ligands' ability to activate FXR. Furthermore, FXR activators induce mRNA for the FXR target genes, phospholipid transfer protein, and the small heterodimer partner. FXR therefore is a functional protein in the vasculature that may provide a direct target for the treatment of proliferative and dyslipidaemic diseases.
Insights
The farnesoid X receptor (FXR) is found in human vasculature and promotes apoptosis in vascular smooth muscle cells. This nuclear receptor may offer a new therapeutic target for cardiovascular and metabolic diseases.
Area of Science:
- Molecular Biology
- Cardiovascular Science
- Endocrinology
Background:
- The farnesoid X receptor (FXR), a nuclear hormone receptor, plays roles in cholesterol and bile acid metabolism.
- FXR ligands are being investigated for cardiovascular disease applications.
- FXR's presence and function in the vasculature were previously not well-defined.
Purpose of the Study:
- To investigate the expression and function of FXR in human cardiovascular tissues.
- To determine the effect of FXR activation on vascular smooth muscle cells.
- To explore FXR as a potential therapeutic target for vascular and metabolic disorders.
Main Methods:
- Analysis of FXR expression in a human cardiovascular tissue array.
- In vitro studies using rat and human vascular smooth muscle cells.
- Treatment of cells with FXR ligands and assessment of apoptosis and target gene mRNA levels.
Main Results:
- FXR is expressed in various human tissues, with high levels detected in the vasculature, liver, small intestine, and kidney.
- FXR is present in vascular smooth muscle cells, and FXR activators induce apoptosis in these cells.
- FXR activation leads to increased mRNA expression of phospholipid transfer protein and small heterodimer partner.
Conclusions:
- FXR is a functional protein within the vasculature.
- FXR activation induces vascular smooth muscle cell apoptosis, suggesting a role in vascular homeostasis.
- FXR represents a potential therapeutic target for proliferative and dyslipidaemic vascular diseases.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Regulation of Angiogenesis and Blood Supply
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical, 7TM, or...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
GPCRs Regulate Adenylyl Cylase Activity
Two...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
